These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21504117)

  • 1. Vitamin E and enzymatic/oxidative stress-driven oxysterols in amnestic mild cognitive impairment subtypes and Alzheimer's disease.
    Iuliano L; Monticolo R; Straface G; Spoletini I; Gianni W; Caltagirone C; Bossù P; Spalletta G
    J Alzheimers Dis; 2010; 21(4):1383-92. PubMed ID: 21504117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
    Solomon A; Leoni V; Kivipelto M; Besga A; Oksengård AR; Julin P; Svensson L; Wahlund LO; Andreasen N; Winblad B; Soininen H; Björkhem I
    Neurosci Lett; 2009 Oct; 462(1):89-93. PubMed ID: 19560513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
    Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
    Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease.
    Baldeiras I; Santana I; Proença MT; Garrucho MH; Pascoal R; Rodrigues A; Duro D; Oliveira CR
    J Alzheimers Dis; 2008 Sep; 15(1):117-28. PubMed ID: 18780972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment.
    Baldeiras I; Santana I; Proença MT; Garrucho MH; Pascoal R; Rodrigues A; Duro D; Oliveira CR
    J Alzheimers Dis; 2010; 21(4):1165-77. PubMed ID: 21504121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between oxysterols and mild cognitive impairment in the elderly: a case-control study.
    Liu Q; An Y; Yu H; Lu Y; Feng L; Wang C; Xiao R
    Lipids Health Dis; 2016 Oct; 15(1):177. PubMed ID: 27724967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin e and intima media thickness progression in end-stage renal disease (VIPER) cohort.
    Boaz M; Iuliano L; Himmelfarb J; Matas Z; Micheletta F; McMonagle E; Friedman V; Natoli S; Gvirtz G; Biro A; Smetana S; Sabo G; Gafter U; Weinstein T
    Nephron Clin Pract; 2005; 100(4):c111-9. PubMed ID: 15849477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.
    Rinaldi P; Polidori MC; Metastasio A; Mariani E; Mattioli P; Cherubini A; Catani M; Cecchetti R; Senin U; Mecocci P
    Neurobiol Aging; 2003 Nov; 24(7):915-9. PubMed ID: 12928050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased apoptosis in the platelets of patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Zhao S; Zhao J; Zhang T; Guo C
    Clin Neurol Neurosurg; 2016 Apr; 143():46-50. PubMed ID: 26895209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
    Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
    J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
    Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R
    Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Baglioni M; Cecchetti R; Kivipelto M; Ruggiero C; Piobbico D; Kussmaul L; Monastero R; Brancorsini S; Mecocci P
    J Alzheimers Dis; 2015; 44(2):649-60. PubMed ID: 25322927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D Increases Aβ140 Plasma Levels and Protects Lymphocytes from Oxidative Death in Mild Cognitive Impairment Patients.
    SanMartin CD; Henriquez M; Chacon C; Ponce DP; Salech F; Rogers NK; Behrens MI
    Curr Alzheimer Res; 2018; 15(6):561-569. PubMed ID: 29283046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.
    Lütjohann D; Papassotiropoulos A; Björkhem I; Locatelli S; Bagli M; Oehring RD; Schlegel U; Jessen F; Rao ML; von Bergmann K; Heun R
    J Lipid Res; 2000 Feb; 41(2):195-8. PubMed ID: 10681402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients.
    Kölsch H; Heun R; Kerksiek A; Bergmann KV; Maier W; Lütjohann D
    Neurosci Lett; 2004 Sep; 368(3):303-8. PubMed ID: 15364416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.
    Mangialasche F; Westman E; Kivipelto M; Muehlboeck JS; Cecchetti R; Baglioni M; Tarducci R; Gobbi G; Floridi P; Soininen H; Kłoszewska I; Tsolaki M; Vellas B; Spenger C; Lovestone S; Wahlund LO; Simmons A; Mecocci P;
    J Intern Med; 2013 Jun; 273(6):602-21. PubMed ID: 23343471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
    Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
    J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial navigation deficit in amnestic mild cognitive impairment.
    Hort J; Laczó J; Vyhnálek M; Bojar M; Bures J; Vlcek K
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4042-7. PubMed ID: 17360474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.